Related Experiment Video
Updated: Jan 2, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Involvement of RUNX and BRD Family Members in Restriction Point
Jung-Won Lee1,2, Tae-Geun Park1,2, Suk-Chul Bae1
1Department of Biochemistry, College of Medicine, Chungbuk National University, Cheongju 28644, Korea.
Abstract:
A tumor is an abnormal mass of tissue that arises when cells divide more than they should or do not die when they should. The cellular decision regarding whether to undergo division or death is made at the restriction (R)-point. Consistent with this, an increasingly large body of evidence indicates that deregulation of the R-point decision-making machinery accompanies the formation of most tumors. Although the R-point decision is literally a matter of life and death for the cell, and thus critical for the health of the organism, it remains unclear how a cell chooses its own fate. Recent work demonstrated that the R-point constitutes a novel oncogene surveillance mechanism operated by R-point-associated complexes of which RUNX3 and BRD2 are the core factors (Rpa-RX3 complexes). Here, we show that not only RUNX3 and BRD2, but also other members of the RUNX and BRD families (RUNX1, RUNX2, BRD3, and BRD4), are involved in R-point regulation.
Insights
Tumor formation is linked to errors in the cell cycle
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Background:
- Tumors arise from abnormal cell division or survival.
- The restriction (R)-point governs cell division and death.
- R-point deregulation is implicated in most tumor development.
Purpose of the Study:
- To investigate the molecular mechanisms underlying R-point regulation.
- To identify key factors involved in the R-point decision-making process.
- To explore the role of RUNX and BRD family members in oncogene surveillance.
Main Methods:
- Analysis of R-point-associated complexes.
- Investigating the function of RUNX and BRD family proteins.
- Utilizing molecular biology techniques to study cell fate decisions.
Main Results:
- R-point regulation involves novel oncogene surveillance mechanisms.
- RUNX3 and BRD2 are core factors in R-point-associated complexes (Rpa-RX3).
- RUNX1, RUNX2, BRD3, and BRD4 also participate in R-point regulation.
Conclusions:
- The RUNX and BRD protein families are crucial for maintaining R-point integrity.
- Dysregulation of these factors contributes to tumor formation.
- Understanding R-point regulation offers potential therapeutic targets for cancer.
Related Concept Videos
Inheritance of Chromatin Structures
Negative Regulator Molecules
Master Transcription Regulators
RNA Polymerase II Accessory Proteins
Restarting Stalled Replication Forks
Regulation of Expression at Multiple Steps

